REG-4basebio UK Societas: Director/PDMR Shareholding

4BasebioAnnouncement

26/02/2021 07:05

26 February 2021

4basebio UK Societas

(the "Company")

Director’s Dealing

4basebio UK Societas (AIM: 4BB), the specialist life sciences group focused on
exploiting its intellectual property in the field of gene therapies and DNA
vaccines, announces that, on 25 February 2021, Heikki Lanckriet, chief
executive officer, acquired 3,000 ordinary shares at an average price of 345
pence per share on behalf of persons closely associated with him.

As a result of the acquisition of ordinary shares, Heikki Lanckriet’s
beneficial holding, including shares held by persons closely associated with
him, comprises 1,240,003 ordinary shares representing 10.07 per cent. of the
Company’s issued share capital.

This announcement contains inside information for the purposes of Article 7 of
EU Regulation 596/2014.

For further enquiries, please contact:

 4basebio UK Societas Heikki Lanckriet                                      +44 (0)1223 967 943 
                                                                                                
 Nominated Adviser Cairn Financial Advisers LLP Jo Tuner / Sandy Jamieson   +44 (0)20 7213 0880 
                                                                                                
 Broker finnCap Ltd Geoff Nash/Richard Chambers/Charlotte Sutcliffe         +44 (0)20 7220 0500 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014                                                                                                                                                                                            
 1   Details of the person discharging managerial responsibilities/person closely associated                                                                                                                                                                                        
 a.  Name                                                                              Heikki Lanckriet                                                                                                                                                                             
 2   Reason for notification                                                                                                                                                                                                                                                        
 a.  Position/Status                                                                   Chief Executive Officer                                                                                                                                                                      
 b.  Initial notification/ Amendment                                                   Initial                                                                                                                                                                                      
 3   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor                                                                                                                                                                  
 a.  Name                                                                              4basebio UK Societas                                                                                                                                                                         
 b.  LEI                                                                               2138005D5SAG8FIR6G91                                                                                                                                                                         
 4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted                                                                              
 a.  Description of the financial instrument, type of instrument  Identification Code  Ordinary Shares   ISIN: GB00BLD8ZL39                                                                                                                                                         
 b.  Nature of the transaction                                                         Acquisition of ordinary shares                                                                                                                                                               
 c.  Price(s) and volume(s)                                                                                                                                                                                                                                                         
                                                                                                                  Volume(s)                  Price (p)                                                                                                                              
     1. 1,000                                                                                                     345p 345p 345p                                                                                                                         
     2. 1,000                                                                                                                                                                                                                                            
     3. 1,000                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                     
 d.  Aggregated information  - Aggregated Volume - Price                               -3,000 -345 pence per share                                                                                                                                                                  
 e.  Date of the transaction                                                           25/2/2021                                                                                                                                                                                    
 f.  Place of the transaction                                                          London Stock Exchange, AIM                                                                                                                                                                   
                                                                                                                                                                                                                                                                                    



Copyright (c) 2021 PR Newswire Association,LLC. All Rights Reserved